Overview
Masanori Imamura practices practicing medicine in Kanazawa, Japan.
His clinical expertise encompasses Mucopolysaccharidosis Type 1 (MPS I, Hurler Syndrome).
He is actively involved in clinical research, co-authoring 24 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Masanori Imamura
Is Masanori Imamura a top-rated expert for Mucopolysaccharidosis Type 1 (MPS I, Hurler Syndrome)?
MediFind is an objective health platform that identifies experts based on real-world data. Masanori Imamura is classified as an Experienced expert for Mucopolysaccharidosis Type 1 (MPS I, Hurler Syndrome), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Masanori Imamura participate in research or clinical trials?
Yes. Masanori Imamura has published 24 articles and abstracts on conditions like Mucopolysaccharidosis Type 1 (MPS I, Hurler Syndrome). You can view a list of Masanori Imamura's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Mucopolysaccharidosis Type 1 (MPS I, Hurler Syndrome)